Chart Advisor: The Ozempic Effect

Articles From: Investopedia
Website: Investopedia

By Michael Nauss, CMT, CAIA, CDMS

1/ Indexes

2/ Diamonds in the Rough

3/ The Ozempic Effect

Investopedia is partnering with CMT Association on this newsletter.  The contents of this newsletter are for informational and educational purposes only, however, and do not constitute investing advice. The guest authors, which may sell research to investors, and may trade or hold positions in securities mentioned herein do not represent the views of CMT Association or Investopedia. Please consult a financial advisor for investment recommendations and services.

1/ Indexes

Yesterday, we talked about weakness under the hood in the equity market. Today, we have stocks following through on that weakness. As always, on weak days, I think it’s useful for investors/traders to search for stocks showing strength and bucking the trend.

2/ Diamonds in the Rough

Most of the stocks that have been holding up well were all low-float names, but one did grab my attention as a possible idea, and that was Weight Watchers (WW), which received an upgrade after starting to incorporate Ozempic in its practice. The chart below shows a nice little breakout in this weak market. 

3/ The Ozempic Effect

After noticing the Ozempic-related move in Weight Watchers (WW) I started to look around for other names that might benefit if the move continues.

Below, we have the creator of the drug Novo Nordisk (NVO). It’s holding well after its recent earnings gap, building a tight base at highs and could be one way to play the continuation. 

Next, we compare Novo Nordisk (NVO) to one of the industries the weight loss drugs could hurt. The below chart shows that as Novo Nordisk (NVO) rallies, McDonalds (MCD) has been selling off. 

For people looking to play both sides of the market, these two may display a correlation for a while yet. As for me, these names will be on my watchlist for a while.

Originally posted 7th September 2023

Join the Discussion

Thank you for engaging with IBKR Campus. If you have a general question, it may already be covered in our FAQs. If you have an account-specific question or concern, please reach out to Client Services.

Your email address will not be published. Required fields are marked *

Disclosure: Investopedia

Investopedia.com: The comments, opinions and analyses expressed herein are for informational purposes only and should not be considered individual investment advice or recommendations to invest in any security or to adopt any investment strategy.  While we believe the information provided herein is reliable, we do not warrant its accuracy or completeness. The views and strategies described on our content may not be suitable for all investors. Because market and economic conditions are subject to rapid change, all comments, opinions and analyses contained within our content are rendered as of the date of the posting and may change without notice. The material is not intended as a complete analysis of every material fact regarding any country, region, market, industry, investment or strategy. This information is intended for US residents only.

Disclosure: Interactive Brokers

Information posted on IBKR Campus that is provided by third-parties does NOT constitute a recommendation that you should contract for the services of that third party. Third-party participants who contribute to IBKR Campus are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from Investopedia and is being posted with its permission. The views expressed in this material are solely those of the author and/or Investopedia and Interactive Brokers is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to buy or sell any security. It should not be construed as research or investment advice or a recommendation to buy, sell or hold any security or commodity. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Disclosure: ETFs

Any discussion or mention of an ETF is not to be construed as recommendation, promotion or solicitation. All investors should review and consider associated investment risks, charges and expenses of the investment company or fund prior to investing. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.